相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The role of microenvironment in tumor angiogenesis
Domenico Ribatti et al.
GENES AND NUTRITION (2008)
Heparanase Stimulation of Protease Expression Implicates It as a Master Regulator of the Aggressive Tumor Phenotype in Myeloma
Anurag Purushothaman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Glypican-1 modulates the angiogenic and metastatic potential of human and mouse cancer cells
Takurna Aikawa et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Bone marrow stroma confers resistance to Apo2 Ligand/TRAIL in multiple myeloma in part by regulating c-FLIP
Lia Elena Perez et al.
JOURNAL OF IMMUNOLOGY (2008)
Extravasation and homing mechanisms in multiple myeloma
Isabelle Vande Broek et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
Syndecan-1: a dynamic regulator of the myeloma microenvironment
Ralph D. Sanderson et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy
Yang Yang et al.
BLOOD (2007)
Heparanase enhances syndecan-1 shedding - A novel mechanism for stimulation of tumor growth and metastasis
Yang Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Targeted therapy of multiple myeloma based upon tumor-microenvironmental interactions
Kenneth C. Anderson
EXPERIMENTAL HEMATOLOGY (2007)
Synopsis of a roundtable on validating novel therapeutics for multiple myeloma
William Dalton et al.
CLINICAL CANCER RESEARCH (2006)
Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myeloma
K. Mahtouk et al.
ONCOGENE (2006)
Enhancement of clonogenicity of human multiple myeloma by dendritic cells
Anjli Kukreja et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Importance of the bone marrow microenvironment in inducing the angiogenic response in multiple myeloma
D. Ribatti et al.
ONCOGENE (2006)
Heparan sulfate in trans potentiates VEGFR-mediated angiogenesis
Lars Jakobsson et al.
DEVELOPMENTAL CELL (2006)
HSulf-1 and HSulf-2 are potent inhibitors of myeloma tumor growth in vivo
YM Dai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Heparin regulates vascular endothelial growth factor165-dependent mitogenic activity, tube formation, and its receptor phosphorylation of human endothelial cells -: Comparison of the effects of heparin and modified heparins
S Ashikari- Hada et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Characterization of clonogenic multiple myeloma cells
W Matsui et al.
BLOOD (2004)
Induction of syndecan-1 expression in stromal fibroblasts promotes proliferation of human breast cancer cells
T Maeda et al.
CANCER RESEARCH (2004)
The syndecan-1 ectodomain regulates αvβ3 integrin activity in human mammary carcinoma cells
DLM Beauvais et al.
JOURNAL OF CELL BIOLOGY (2004)
Role of the bone marrow microenvironment in multiple myeloma
GD Roodman
JOURNAL OF BONE AND MINERAL RESEARCH (2002)
Soluble syndecan-1 promotes growth of myeloma tumors in vivo
Y Yang et al.
BLOOD (2002)
Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma
PWB Derksen et al.
BLOOD (2002)
Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: Shed syndecan-1 accumulates in fibrotic regions
IB Bayer-Garner et al.
MODERN PATHOLOGY (2001)
Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice
CM Alexander et al.
NATURE GENETICS (2000)
分享论文
